Most Recent

Why social media speech is not free

Why social media speech is not free

Many people are now noticing the harmful effects social media can have. These may range from social isolation, anxiety, depression and distortion of body image,…

The First Truly Effective Weight Loss Drug Arrives

It looks like the first truly effective weight loss drug has arrived. Learn the basic facts about semaglutide and get perspectives from Milton Packer and Sanjay Kaul on what lies ahead.

A Schooling in Side Effects

The other day, I had the pleasure of being corrected by ever-impressive Milton Packer and I feel obliged to share his teachings with you. The…

Trials in Heart Failure with Preserved Ejection Fraction: An Interview with Steve Nissen and Milton Packer

Faiez Zannad moderates a fascinating discussion between Milton Packer and Steve Nissen about the PARAGON-HF trial in heart failure with preserved ejection fraction. Nissen was…

Load More

Mission statement

CVCT CardioBrief will provide a platform for a diverse spectrum of opinions and perspectives on issues of interest to the cardiovascular clinical trials community. We aim to promote rigorous, unbiased, and patient-centred scientific discourse and debate within the cardiovascular community. CVCT CardioBrief does not seek to compete with medical journals or other traditional forums; instead we seek to create an accessible and responsive forum for discussion about important cardiovascular trials and other significant developments. It is our goal to provide a voice for perspectives that may not have always been able to gain exposure and consideration in traditional settings.

CVCT CardioBrief is an expansion of the CardioBrief website and is published by the CVCT Forum.

Would you like to write for CVCT CardioBrief? We are looking for brief original contributions of interest to the broad cardiovascular clinical trial community. We also invite readers to respond to posts and take part in the discussion on the site. Please send inquries or submissions to